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Background
Methicillin‑resistant Staphylococcus aureus (MRSA) is a current health concern, although
patients undergoing elective, routine ENT surgery are excluded from this concern.
Staphylococcus aureus is a common cause of ENT bacterial infections.

Objectives

To know the epidemiology and risk factors of MRSA complicated otorhinolaryngological cases
at Khartoum ENT hospitals in 2017.

Patients and methods

This is a prospective, cross‑sectional, descriptive, analytical hospital‑based study conducted on
155 patients in the period from December 2016 to December 2017. Of the patients, 50% were
from Omdurman Hospital, 30% from Ibn Sina Hospital and 20% from Africa hospital. Patients’
data were collected through a data collection sheet. Different ENT swabs were taken from the
patients and were sent to the microbiology laboratory in the University of Khartoum for culture
and sensitivity. Data were analyzed using SPSS, version 22 and Excel 2010.

Results

Most patients of MRSA were from the age group of 21–30 years (33.3%). Males with MRSA were
more (61.9%) with a male to female ratio of 1.63:1.00. Most of MRSA swabs were taken from
the ear (57.1%). Ciprofloxacin (55%) was the most common previous antibiotic used in MRSA
patients. Meropenem (52.4%) was the most sensitive antibiotics in MRSA patients. Diabetic,
hypertensive, steroid use, chronic obstructive pulmonary disease, asthmatic, and admitted
patients constitute 6.3, 8.3, 20.8, 41.6, and 47.9% of total patient percentage, respectively.

Conclusion

MRSA is highly prevalent among the populations of S. aureus isolated from different ENT
clinical specimens in different hospitals in Khartoum State, with most of the MRSA isolates
being from ear infections. The highest antibiotic sensitivity to MRSA was meropenem. Risk
factors such as hypertension, diabetes, steroid use, chronic obstructive pulmonary disease,
asthma, and previous admission have contributed to MRSA.
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Introduction
Methicillin‑resistant Staphylococcus aureus (MRSA)
is
a
common
pathogen
implicated
in
hospital‑acquired infection. Routine screening for
MRSA is a current health policy, although patients
undergoing elective, routine ENT surgery are
excluded from this policy. Staphylococcus aureus is
a common cause of bacterial infections, including
superficial skin infections, wound infections and
deep abscesses, and also a common nasal commensal
in fit individuals [1].

Patients and methods
This is a prospective, cross‑sectional, descriptive,
analytical, hospital‑based study on 155 patients
in Khartoum State ENT Hospitals Omdurman

Hospital, Ibn Sina Hospital, and Africa Hospital from
December 2016 to December 2017. Of the patients,
50% were from Omdurman Hospital, 30% from Ibn
Sina Hospital, and 20% from Africa hospital. Patients’
data were collected through a data collection sheet
designed to satisfy the objectives. Samples were taken
from the patients using laboratory swabs which were
closed tightly. Swabs were sent to the microbiology
laboratory in Khartoum University in the same day in
which culture and sensitivity had been done. Then data
were collected and analyzed using SPSS, version 22
and Excel 2010 produced by IBM SPSS Inc.
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Results
The largest number of patients were from the age
group of between 1 and 10 years with 56 (36.1%)
patients, then the age groups between 21 and 30, 11
and 20, 31 and 40, and above 50 years with 37 (23.9%),
33 (21.3%), 21 (13.5%), and five (3.2%) patients,
respectively. The least age group was between 41 and
50 years with only three (1.9%) patients. The mean age
group was between 11 and 20 years and the mean age
was 17.5 years. Males were 74 (47.7%), females were
81 (52.3%) with a male to female ratio of 0.91:1.00.
One hundred percent of patients used antibiotics
without response. The antibiotics used were gentamicin
in 67 (43.2%) patients, ciprofloxacin in 67 (43.2%)
patients, ceftriaxone in 18 (11.3%) patients, and other
antibiotics in three (2.3%) patients. Swabs taken from
the ear were 84 (54.2%), from the throat 45 (29.1%),
from the nose 21 (13.5%), and only five (3.2%) from
other sites. S. aureus is found in 48 (31%) patients and
other organisms were found in 107 (69%). Most of
the patients with S. aureus were MRSA in 42 (87.5%)
patients and only six (12.5%) patients had MRSA.
Regarding other organisms cultured, there were
streptococcus in 14 (13.1%) patients, pseudomonas in
11 (10.3%) patients, Corynebacteria in eight (7.5%)
patients, Klebsiella in seven (6.5%) patients,
Enterobacteria in four (3.7%) patients, bacillus in
three (2.8%) patients, fungi in two (1.9%) patients,
and Proteus in one (0.9%) patient and no growth in
57/107 (53.3%) patients.
Regarding antibiotic sensitivity, the first choice and the
most sensitive antibiotic was meropenem in 36 (37.9%),
while the second choice was imipenem in 22 (23.2%),
ceftazidime was the third choice in 11 (11.6%),
clindamycin in nine (9.5%), chloramphenicol in
eight (8.4%), cefuroxime in five (5.3%), ciprofloxacin
in three (3.2%), and doxycycline in one (1.1%). Risk
factor results showed that diabetes was found in
13 (8.4%) patients, hypertension in 13 (8.4%) patients,
and those who use steroids were 15 (9.7%) patients,
while chronic obstructive pulmonary disease (COPD)
patients were 10 (6.5%), asthma patients were
30 (19.4%). History of previous admission was found
in 48 (31%) patients. Regarding the cases of MRSA
in relation to age distribution: the largest numbers of
patients were from the age groups between 21 and
30 with 14 (33.3%) patients, then the group between
11 and 21 with 13 (31%) patients and between 1 and
10 with 11 (26.2%) patients with P value less than
0.05 (Fig. 1). MRSA in relation to sex, males with
MRSA were 26 (61.9%) and females with MRSA
were 16 (38.1%) with male to female ratio (1.63:1.00)
with P value less than 0.05 (Fig. 2). MRSA and site
of the swab correlation showed that most of it were
taken from the ear 24 (57.1%), then from the throat
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14 (33.3%) and from the nose four (9.5%) with
P value less than 0.05 (Fig. 3). MRSA in relation to
Figure 1
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previous antibiotic used illustrates that ciprofloxacin
was the highest percentage in 23 (55%) patients,
then gentamicin in 15 (35%) patients, and the lowest
percentage was ceftriaxone in two (5%) patients, and
other antibiotics in two (5%) patients with P value less
than 0.05 (Fig. 4). MRSA and antibiotic sensitivity
results reveal that meropenem was the most sensitive in
22 (52.4%) patients, then imipenem in eight (19.1%)
patients, ceftazidime in five (11.9%) patients,
cefuroxime in four (9.7%) patients, clindamycin in
two (4.7%) patients, and chloramphenicol in one (1.3%)
patient with P value less than 0.05 (Fig. 5). The relation
between MRSA and risk factors showed that diabetic
and hypertensive patients were three (7.1%) for each,
while steroid was used in four (9.5%) patients. COPD
patients were 10 (23.8%), asthma patients were
20 (47.6%), and patients with a history of admission
were 23 (54.8%) patients with a P value less than 0.05.

Discussion
The largest number of participants were in the age
group between 1 and 10 years (36.1%), and that is in
contrast to the results of the Ringberg et al. [2] study
in which they found that the elderly group were the
dominant age group and the study by Suliman et al. [3]
in which he found that the age group between 18 and
25 years was the dominant one. Females (52.3%) were
more than males (47.7%) in the study and that was
similar to the Suliman et al. [3] study in which he
found that females (60%) were more than males (40%).
The largest number of swabs were those taken from
the ear (54.2%), and that was similar to the Elimam
et al. [4] study in which ear swabs (120, 28.4%) was
the largest swabs, and different from the Ringberg
et al. [2] study in which throat swabs (146, 55%)
were the most prevalent. The most sensitive antibiotic
Figure 4

Regarding the risk factors diabetic patients were
13 (8.4%), hypertensive were 13 (8.4%), patients on
steroids were 15 (9.7%), those with a history of COPD
were 10 (6.5%); asthma patients were 30 (19.4%) and
about 48 (31%) of patients have a history of admission
and that was similar to the study by Coello et al. [7]
in which he found that 53/479 (11%) have MRSA
and they have associated risk factors like previous
multiple antibiotic use and hospital or intensive care
admission. All patients have a past history of antibiotic
uses (100%) and that was similar to the Thirumazhisi
Sachithanandam [8] study in which 100% used
multiple antibiotics. S. aureus constitute 31% of the
organisms, others were 69%. Results of those with
other bacterial growth reveal streptococcus in 13.1%,
pseudomonas in 10.3%, and corynebacteria in 7.5%,
and that was similar to the studies by Mukhtar and
Saeed [5] and the study by Yagoub and Sulieman [6]
in which Staphylococcus and Streptococcus and other
species were also cultured. Most of S. aureus were
MRSA (87.5%), and this is similar to the study done
by Choi et al. [9] in which MRSA (28.1%) was the
most prevalent bacteria.
Regarding the cases of MRSA in relation to age
distribution: the largest numbers of patients were
from the age groups of between 21 and 30 years with
14 (33.3%) patients, and that was similar to the study
done by Suliman et al. [3] in which he found that the
age group between 18 and 25 years was the dominant
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one, but that is in contrast to the results of Ringberg
et al. [2] study in which he found that the elderly group
were the dominant age group. Regarding MRSA in
relation to sex, males with MRSA were 26 (61.9%)
and females with MRSA were 16 (38.1%) with a male
to female ratio of 1.63:1.00 and that was different to
the Suliman et al. [3] study in which he found that
females (60%) were more than males (40%). MRSA
and site of the swab correlation showed that most of
it were taken from the ear 24 (57.1%), and that was
similar to the Elimam et al. [4] study in which ear
swab 120 (28.4%) was the largest number of swabs,
and different from Ringberg et al. [2] study in which
throat swabs 146 (55%) were the most prevalent.
MRSA and antibiotic sensitivity results reveal that
meropenem was the most sensitive in 22 (52.4%)
patients, then imipenem in eight (19.1%) patients,
ceftazidime in five (11.9%) patients, and that was
similar to a study done by Mukhtar and Saeed [5] in
which he found the sensitivity for imipenem (100%)
and ceftazidime (100%), and in contrast to the study
done by Yagoub and Sulieman [6] in which they found
ciprofloxacin and gentamicin were the most sensitive
antibiotics. The relation between MRSA and risk
factors showed that diabetic and hypertensive patients
were three (7.1%) for each, while steroid were used in
four (9.5%) patients; COPD patients were 10 (23.8%).
Asthma patients were 20 (47.6%) and patients with
a history of admission were 23 (54.8%) patients, and
that was similar to the study done by Coello et al. [7]
in which he found that 53/479 (11%) have MRSA and
they have associated risk factors like previous multiple
antibiotic use and hospital or intensive care admission.

Conclusion
MRSA is highly prevalent among populations
of S. aureus isolated from different ENT clinical
specimens in different hospitals in Khartoum State,
with most of the MRSA isolates being from ear
infections. Highest antibiotic sensitivity to MRSA was
meropenem, imipenem, and ceftazidime. Risk factors
such as hypertension, diabetes, steroid use, and COPD
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have weak contribution to MRSA, where asthma and
previous admission have a stronger contribution to
MRSA.
Recommendations

The study recommended a clinical and cost‑effective
rapid screening methods such as PCR for MRSA
detection and more studies should be carried out to
determine the sensitivity and clinical effectiveness of
different screening strategies for considering patients
free from MRSA carriage.
Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

1 Robb PJ, Bendig J. Prevalence of MRSA in elective day case pediatric
ENT surgical patients. Int J Pediatr Otorhinolaryngol 2010; 74:1430–1431.
2 Ringberg H, Peterson AC, Walder M, Johansson PJH. The throat:
an important site for MRSA colonization. Scand J Infect Dis 2006;
38:888–893.
3 Suliman FE. Etiology of ear infection among Sudanese patients attending
Khartoum Ear, Nose and Throat Hospital [doctoral dissertation]. Sudan:
Sudan University of Science & Technology; 2015.
4 Elimam MA, Rehan S, Elmekki MA, Elhassan MM. Emergence of
vancomycin resistant and methcillin resistant Staphylococus aureus in
patients with different clinical manifestations in Khartoum State, Sudan.
J Am Sci 2014; 10:106–110.
5 Mukhtar AM, Saeed HA. Profile of antibiotic sensitivity and resistance of
some pathogenic bacteria isolated from clinical specimens in Sudan. J Sci
Technol 2011; 12:14–19.
6 Yagoub M, Sulieman S. Bacterial etiology of acute otitis media among
children attending Khartoum Ear Nose Throat Teaching Hospital in 2014.
Microbiology Research International 2017; 5:25–9.
7 Coello R, Glynn JR, Gaspar C, Picazo JJ, Fereres J. Risk
factors for developing clinical infection with methicillin‑resistant
Staphylococcus aureus (MRSA) amongst hospital patients initially only
colonized with MRSA. J Hosp Infect 1997; 37:39–46.
8 Thirumazhisi
Sachithanandam
S.
Rising
methicillin‑resistant
Staphylococcus aureus infections in ear, nose, and throat diseases. Case
Rep Otolaryngol 2014; 2014:253945.
9 Choi HG, Park KH, Park SN, Jun BC, Lee DH, Yeo SW. The appropriate
medical management of methicillin‑resistant Staphylococcus aureus in
chronic suppurative otitis media. Acta Otolaryngol 2010; 130:42–46.

